Loading data
CVKDNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Cost of revenue | — | — | 220.1 k USD |
| Research and development expense | 4.1 m USD | 4.21 m USD | 4.08 m USD |
| Operating profit | -13.46 m USD | -10.96 m USD | -7.63 m USD |
| Net income (reported basis) | -13.2 m USD | -10.65 m USD | -8.36 m USD |
| Net income attributable to common shareholders | -13.24 m USD | -10.65 m USD | — |
| Basic earnings per share | -6.64 USD/share | -8.73 USD/share | -0.62 USD/share |
| Diluted earnings per share | -6.64 USD/share | -8.73 USD/share | -0.62 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.